Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy

被引:10
作者
Vulpe, H. [1 ]
Kwan, J. Y. Y. [1 ]
McNiven, A. [1 ]
Brierley, J. D. [1 ]
Tsang, R. [1 ]
Chan, B. [1 ,2 ]
Goldstein, D. P. [3 ]
Le, L. W. [4 ]
Hope, A. [1 ]
Giuliani, M. [1 ]
机构
[1] Univ Toronto, Princess Margaret Canc Ctr, Dept Radiat Oncol, Toronto, ON, Canada
[2] Univ Toronto, Princess Margaret Canc Ctr, Radiat Med Program, Toronto, ON, Canada
[3] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada
[4] Univ Toronto, Princess Margaret Canc Ctr, Dept Biostat, Toronto, ON, Canada
关键词
Thyroid neoplasms; recurrence; radiotherapy; anaplastic thyroid carcinoma; papillary carcinoma; EXTERNAL-BEAM RADIATION; RADIOACTIVE IODINE; SINGLE-INSTITUTION; NODAL METASTASIS; NECK DISSECTION; RECURRENCE; CANCER; HEAD; TOXICITY; THERAPY;
D O I
10.3747/co.24.3551
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The radiotherapy (RT) volumes in anaplastic (ATC) and differentiated thyroid carcinoma (DTC) are controversial. Methods We retrospectively examined the patterns of failure after postoperative intensity-modulated RT for ATC and DTC. Computed tomography images were rigidly registered with the original RT plans. Recurrences were considered in-field if more than 95% of the recurrence volume received 95% of the prescribed dose, out-of-field if less than 20% received 95% of the dose, and marginal otherwise. Results Of 30 DTC patients, 4 developed regional recurrence: 1 being in-field (level III), and 3 being out-of-field (all level II). Of 5 ATC patients, all 5 recurred at 7 sites: 2 recurrences being local, and 5 being regional [2 marginal (intramuscular to the digastric and sternocleidomastoid), 3 out-of-field (retropharyngeal, soft tissues near the manubrium, and lateral to the sternocleidomastoid)]. Conclusions In DTC, locoregional recurrence is unusual after RT. Out-of-field DTC recurrences infrequently occurred in level II. Enlarged treatment volumes to level II must be balanced against a potentially greater risk of toxicity.
引用
收藏
页码:E226 / E232
页数:7
相关论文
共 32 条
  • [1] Patterns of relapse following radiotherapy for differentiated thyroid cancer: Implication for target volume delineation
    Azrif, Muhammad
    Slevin, Nicholas J.
    Sykes, Andrew J.
    Swindell, Ric
    Yap, Beng K.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 89 (01) : 105 - 113
  • [2] Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma
    Bardet, Stephane
    Malville, Elodie
    Rame, Jean-Pierre
    Babin, Emmanuel
    Samama, Guy
    De Raucourt, Dominique
    Michels, Jean-Jacques
    Reznik, Yves
    Hecnry-Amar, Michel
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (04) : 551 - 560
  • [3] Prognostic factors and the effect of treatment with radioactive iodine and external beam radiation on patients with differentiated thyroid cancer seen at a single institution over 40 years
    Brierley, J
    Tsang, R
    Panzarella, T
    Bana, N
    [J]. CLINICAL ENDOCRINOLOGY, 2005, 63 (04) : 418 - 427
  • [4] Update on External Beam Radiation Therapy in Thyroid Cancer
    Brierley, James D.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (08) : 2289 - 2295
  • [5] Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition
    Chow, Sin-Ming
    Yau, Stephen
    Kwan, Chung-Kong
    Poon, Patricia C. M.
    Law, Stephen C. K.
    [J]. ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1159 - 1172
  • [6] Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer (vol 19, pg 1167, 2009)
    Cooper, D. S.
    Doherty, G. M.
    Hauger, B. R.
    Kloos, R. T.
    Lee, S. L.
    Mandel, S. J.
    Mazzaferri, E. L.
    McIver, B.
    Pacini, F.
    Schlumberger, M.
    Sherman, S., I
    Steward, D. L.
    Tuttle, R. M.
    [J]. THYROID, 2010, 20 (06) : 674 - 675
  • [7] HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR ANAPLASTIC THYROID CARCINOMA: TOXICITY AND SURVIVAL ANALYSIS
    Dandekar, Prasad
    Harmer, Clive
    Barbachano, Yolanda
    Rhys-Evans, Peter
    Harrington, Kevin
    Nutting, Christopher
    Newbold, Kate
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (02): : 518 - 521
  • [8] Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer
    Dawson, LA
    Anzai, Y
    Marsh, L
    Martel, MK
    Paulino, A
    Ship, JA
    Eisbruch, A
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (05): : 1117 - 1126
  • [9] Results of combined treatment of anaplastic thyroid carcinoma (ATC)
    Derbel, Olfa
    Limem, Sami
    Segura-Ferlay, Celine
    Lifante, Jean-Christophe
    Carrie, Christian
    Peix, Jean-Louis
    Borson-Chazot, Francoise
    Bournaud, Claire
    Droz, Jean-Pierre
    de la Fouchardiere, Christelle
    [J]. BMC CANCER, 2011, 11
  • [10] Long-term results of radiotherapy in anaplastic thyroid cancer
    Dumke, Anne-Katrin
    Pelz, Tanja
    Vordermark, Dirk
    [J]. RADIATION ONCOLOGY, 2014, 9